1. Weng, Jialei, Liu, Shaoqing, Zhou, Qiang, Zhou, Chenhao, Ren, Ning. . Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. In Journal for immunotherapy of cancer, 11, . doi:10.1136/jitc-2022-006655. https://pubmed.ncbi.nlm.nih.gov/37385725/
2. Sheth, Jayesh, Mistri, Mehul, Bhavsar, Riddhi, Shah, Raju, Sheth, Frenny. 2018. Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients. In BMC neurology, 18, 203. doi:10.1186/s12883-018-1206-1. https://pubmed.ncbi.nlm.nih.gov/30541466/
3. Mondal, Avisek, Appu, Abhilash P, Sadhukhan, Tamal, Liu, Aiyi, Mukherjee, Anil B. 2022. Ppt1-deficiency dysregulates lysosomal Ca++ homeostasis contributing to pathogenesis in a mouse model of CLN1 disease. In Journal of inherited metabolic disease, 45, 635-656. doi:10.1002/jimd.12485. https://pubmed.ncbi.nlm.nih.gov/35150145/
4. Murgiano, Leonardo, Becker, Doreen, Torjman, Dina, Leeb, Tosso, Aguirre, Gustavo D. 2019. Complex Structural PPT1 Variant Associated with Non-syndromic Canine Retinal Degeneration. In G3 (Bethesda, Md.), 9, 425-437. doi:10.1534/g3.118.200859. https://pubmed.ncbi.nlm.nih.gov/30541930/
5. Yuan, Wei, Lu, Liaoxun, Rao, Muding, Zhang, Zhongjian, Kong, Eryan. . GFAP hyperpalmitoylation exacerbates astrogliosis and neurodegenerative pathology in PPT1-deficient mice. In Proceedings of the National Academy of Sciences of the United States of America, 118, . doi:10.1073/pnas.2022261118. https://pubmed.ncbi.nlm.nih.gov/33753498/
6. Scifo, Enzo, Szwajda, Agnieszka, Soliymani, Rabah, Baumann, Marc H, Lalowski, Maciej. 2015. Quantitative analysis of PPT1 interactome in human neuroblastoma cells. In Data in brief, 4, 207-16. doi:10.1016/j.dib.2015.05.016. https://pubmed.ncbi.nlm.nih.gov/26217791/
智鼠故事 
